BNC Korea Co., Ltd. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 5,130.00
-40.00 (-0.77%)
Sep 16, 2025, 3:30 PM KST
BNC Korea Market Cap
BNC Korea has a market cap or net worth of 350.87 billion as of September 16, 2025. Its market cap has decreased by -21.77% in one year.
Market Cap
350.87B
Enterprise Value
279.29B
Revenue
99.34B
Ranking
n/a
PE Ratio
22.02
Stock Price
5,130.00
Market Cap Chart
Since November 18, 2019, BNC Korea's market cap has increased from 15.37B to 350.87B, an increase of 2,182.28%. That is a compound annual growth rate of 70.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 350.87B | 27.24% |
| Dec 30, 2024 | 275.74B | 12.30% |
| Dec 28, 2023 | 245.55B | -20.03% |
| Dec 29, 2022 | 307.06B | -78.68% |
| Dec 30, 2021 | 1,440.31B | 557.65% |
| Dec 30, 2020 | 219.01B | 174.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.88T |
| Celltrion | 37.82T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,955.07B |
| SK Biopharmaceuticals | 8,692.77B |
| Peptron | 7,152.29B |
| PharmaResearch | 6,690.93B |
| ABL Bio | 5,746.76B |